menu search

Streaming stock could continue to climb if past is precedent

Spotify Technology SA (NYSE:SPOT) is up 1.8% to trade at $160.22 this afternoon, as the broader market waxes and wanes while investors ...

July 11, 2023, 1:51 pm

3 crypto stocks to watch as fed ponders on interest rates

MARA, IBKR and MOGO are three crypto-exposed stocks that should be tracked as the Fed decides on the way forward with interest rates....

July 11, 2023, 9:32 am

Gold price forecast: underpinned by weaker dollar as investors await us inflation data

Gold is steady as investors await U.S. inflation data, eyeing its influence on Fed policy as the central bank ...

July 11, 2023, 1:59 am

Stocks may head higher this year as bulls have history on their side

As U.S. stock investors ponder what lies ahead in the rest of 2023, bulls have history on their side—...

July 8, 2023, 8:15 am

Could drax group be the world's largest carbon removal companies, asks barclays?

Could Drax Group (LSE:DRX) be the world's largest carbon removal companies, Barclays pondered, despite ...

July 6, 2023, 8:04 am

Ai, esg come together in this etf

With artificial intelligence (AI) accounting for a significant portion of broader market ebullience this year, some investors are ...

June 15, 2023, 10:33 am

3 ai stocks to take some profits on right now

Are you wondering when to start trimming winning investments? If you have significant stakes in AI stocks, you're likely ...

June 6, 2023, 10:01 am

Bitcoin records first monthly loss of 2023 as fed ponders additional rate hikes

Bitcoin fell about 4.6% in May. Photo illustration by Fortune; original photos by Getty Images (Some Fortune Crypto pricing data is provided by Binanc...

May 31, 2023, 3:44 pm

Why activision blizzard remains undervalued

The impressive rise in tech stocks recently is thanks in large part to the frenzy going on in artificial intelligence (AI) stocks. After the euphoric ...

May 31, 2023, 11:11 am

Gold price finds traction as us dollar pauses despite higher yields

Gold continues to consolidate today after looking lower last week as the US Dollar ponders direction wi...

May 23, 2023, 2:00 am

Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:05 pm

Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:05 pm

Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:05 pm

Nexcella announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinical tria

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:05 pm

Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:00 pm

Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:00 pm

Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:00 pm

Immix biopharma announces positive nxc-201 clinical results at asgct: 100% overall response rate in darzalex-relapsed/refractory al amyloidosis with zero icans in ongoing nexicart-1 phase 1b/2a clinic

8 AL Amyloidosis patients relapsed/refractory to DARZALEX®-based regimens were treated with CAR-T NXC-201 100% (8/8) overall response rate and 63% (5...

May 21, 2023, 8:00 pm

Nokia (nok) to power belgium's first nationwide drone network

The first-of-its-kind contract by Nokia (NOK) will equip the first responders with a 5G automated drone...

May 17, 2023, 11:17 am

Eur/usd price forecast: eurusd grinds higher despite industrial production slump

EURUSD holds above support at 1.0840 for now as weak data gives Euro bulls something to ponder. Where t...

May 15, 2023, 11:48 am


Search within

Pages Search Results: